SCI Abstract

search
+
Liver disease care amid wars and conflicts
This Comment highlights the effects of war- and armed conflict-related healthcare disruptions on chronic liver conditions ...
Human deskilling in medical artificial intelligence: prohibited or permissible under the EU Artificial Intelligence Act?
Artificial intelligence is rapidly being adopted in healthcare, but studies have shown a ‘deskilling’ phenomen...
Cirrhosis, portal hypertension and hepatocellular carcinoma: a stage-based approach
Cirrhosis, portal hypertension and hepatocellular carcinoma: a stage-based approach
Cirrhosis and hepatocellular carcinoma (HCC) are interconnected outcomes of chronic liver disease, with portal hypertensio...
Understanding development and cellular plasticity in the pancreas in health and disease
Understanding development and cellular plasticity in the pancreas in health and disease
Pancreatic development is a dynamic process shaped by coordinated interactions between surrounding non-pancreatic tissues ...
Digestive Disease Week 2026
From 2 to 5 May 2026, Nature Reviews Gastroenterology & Hepatology attended Digestive Disease Week in Chicago, USA. Ac...
Sequencing what we eat
Dietary assessment commonly relies on asking people what they remember eating. Genomic methods can change this assessment,...
Precision nutrition for the prevention and management of inflammatory bowel disease
Precision nutrition for the prevention and management of inflammatory bowel disease
The rising disease burden of inflammatory bowel disease (IBD) parallels the changing dietary landscape accompanying indust...
Identifying MASLD patient eligibility for pharmacological therapy: the need to integrate evidence into clinical practice
Identifying MASLD patient eligibility for pharmacological therapy: the need to integrate evidence into clinical practice
Metabolic dysfunction-associated steatotic liver disease is a leading cause of chronic liver disease, with rising liver tr...
Is precision microbiome medicine just around the corner?
Is precision microbiome medicine just around the corner?
A study in Nature Medicine developed a new clinical test based on a gut metagenome-derived multispecies biomarker panel fo...
MASLD as a non-communicable disease
Non-communicable diseases represent the primary cause of mortality and morbidity globally, accounting for 74% of all death...
New potent HBV replication inhibitors for the management of chronic hepatitis B are needed
New potent HBV replication inhibitors for the management of chronic hepatitis B are needed
With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue t...
Bridging the gap between science and survival
Bridging the gap between science and survival
A scientist’s personal journey through breast cancer underscores the urgency for greater empathy in research and hea...
Author Correction: Understanding the therapeutic toolkit for inflammatory bowel disease
Hepato-Gastroenterology and Digestive Oncology, University Hospital CHU of Liège, Liège, BelgiumSophie VieujeanDepartment ...
Neuroimmune interactions influence pancreatic glucagon secretion in fasting mice
In a new study published in Science, researchers identify a mechanism in mice by which the nervous and immune systems inte...
Influence of biological sex in inflammatory bowel diseases
Influence of biological sex in inflammatory bowel diseases
The incidence of inflammatory bowel disease (IBD) has risen in the past decades and has emerged as a global health issue. ...
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
Μetabolic dysfunction-associated steatotic liver disease (MASLD) comprises a heterogeneous condition in the presence ...
RET signalling controls gut motility
RET signalling controls gut motility
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obta...
New options for late-line treatment of metastatic colorectal cancer
New options for late-line treatment of metastatic colorectal cancer
Metastatic colorectal cancer is a heterogeneous disease associated with poor patient outcomes. Although the past ...
Gut microbiota in overweight and obesity: crosstalk with adipose tissue
Gut microbiota in overweight and obesity: crosstalk with adipose tissue
Overweight and obesity are characterized by excessive fat mass accumulation produced when energy intake exceeds energy exp...
Microbiota-based biomarkers and therapeutics for cancer management
Microbiota-based biomarkers and therapeutics for cancer management
New light is being shed on the interactions between the gut microbiome, cancer cell signalling and the host immune respons...
Tumour-associated macrophages and pancreatic cancer: an inflammatory loop
Tumour-associated macrophages and pancreatic cancer: an inflammatory loop
In a new study published in Nature, researchers have investigated the role of tumour-associated macrophages (TAMs) in panc...
Upgrading therapeutic ambitions and treatment outcomes
Upgrading therapeutic ambitions and treatment outcomes
Important studies published in 2023 outlined new agents and strategies for the management of inflammatory bowel disease. T...
Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases
Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases
Steatotic liver disease has emerged as an important risk factor for cardiovascular disease, type 2 diabetes mellitus and c...
Elafibranor in primary biliary cholangitis
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obta...
Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer
Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer
Surgical resection combined with systemic chemotherapy is the cornerstone of treatment for patients with localized pancrea...
Resmetirom safe for nonalcoholic fatty liver disease
A 52-week randomized, double-blind, placebo-controlled phase III trial (MAESTRO-NAFLD-1) evaluated the safety of resmetiro...
Risk of HCC in individuals of sub-Saharan ethnicity or descent with chronic hepatitis B in Europe
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obta...
See the reality again in the field of liver transplantation
In 2023, we witnessed advances in allocation policies and marginal donors, including living donors. Key improvements inclu...
Amitriptyline as second-line treatment for IBS in primary care settings
Titrated low-dose amitriptyline (a tricyclic antidepressant) was superior to placebo as a second-line treatment for irrita...
Fresh perspectives on how to build, maintain and repair the ENS
Fresh perspectives on how to build, maintain and repair the ENS
Enteric nervous system function is essential for survival. Studies published in 2023 have provided important novel insight...
Load More
format_indent_increase